98 related articles for article (PubMed ID: 25458463)
1. Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis.
Calabrese C; Tosco A; Abete P; Carnovale V; Basile C; Magliocca A; Quattrucci S; De Sanctis S; Alatri F; Mazzarella G; De Pietro L; Turino C; Melillo E; Buonpensiero P; Di Pasqua A; Raia V
J Cyst Fibros; 2015 Mar; 14(2):203-10. PubMed ID: 25458463
[TBL] [Abstract][Full Text] [Related]
2. Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs.
Hartl D; Starosta V; Maier K; Beck-Speier I; Rebhan C; Becker BF; Latzin P; Fischer R; Ratjen F; Huber RM; Rietschel E; Krauss-Etschmann S; Griese M
Free Radic Biol Med; 2005 Aug; 39(4):463-72. PubMed ID: 16043018
[TBL] [Abstract][Full Text] [Related]
3. Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial.
Griese M; Kappler M; Eismann C; Ballmann M; Junge S; Rietschel E; van Koningsbruggen-Rietschel S; Staab D; Rolinck-Werninghaus C; Mellies U; Köhnlein T; Wagner T; König S; Teschler H; Heuer HE; Kopp M; Heyder S; Hammermann J; Küster P; Honer M; Mansmann U; Beck-Speier I; Hartl D; Fuchs C; ; Hector A
Am J Respir Crit Care Med; 2013 Jul; 188(1):83-9. PubMed ID: 23631796
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis.
Bishop C; Hudson VM; Hilton SC; Wilde C
Chest; 2005 Jan; 127(1):308-17. PubMed ID: 15653998
[TBL] [Abstract][Full Text] [Related]
5. Increasing sputum levels of gamma-glutamyltransferase may identify cystic fibrosis patients who do not benefit from inhaled glutathione.
Corti A; Griese M; Hector A; Pompella A
J Cyst Fibros; 2017 May; 16(3):342-345. PubMed ID: 27988297
[TBL] [Abstract][Full Text] [Related]
6. Oral reduced L-glutathione improves growth in pediatric cystic fibrosis patients.
Visca A; Bishop CT; Hilton S; Hudson VM
J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):802-10. PubMed ID: 25633497
[TBL] [Abstract][Full Text] [Related]
7. Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function.
Accurso FJ; Moss RB; Wilmott RW; Anbar RD; Schaberg AE; Durham TA; Ramsey BW;
Am J Respir Crit Care Med; 2011 Mar; 183(5):627-34. PubMed ID: 21169471
[TBL] [Abstract][Full Text] [Related]
8. The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection -- a pilot study.
Skov M; Pressler T; Lykkesfeldt J; Poulsen HE; Jensen PØ; Johansen HK; Qvist T; Kræmer D; Høiby N; Ciofu O
J Cyst Fibros; 2015 Mar; 14(2):211-8. PubMed ID: 25458464
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.
Conrad C; Lymp J; Thompson V; Dunn C; Davies Z; Chatfield B; Nichols D; Clancy J; Vender R; Egan ME; Quittell L; Michelson P; Antony V; Spahr J; Rubenstein RC; Moss RB; Herzenberg LA; Goss CH; Tirouvanziam R
J Cyst Fibros; 2015 Mar; 14(2):219-27. PubMed ID: 25228446
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.
Deterding R; Retsch-Bogart G; Milgram L; Gibson R; Daines C; Zeitlin PL; Milla C; Marshall B; Lavange L; Engels J; Mathews D; Gorden J; Schaberg A; Williams J; Ramsey B;
Pediatr Pulmonol; 2005 Apr; 39(4):339-48. PubMed ID: 15704203
[TBL] [Abstract][Full Text] [Related]
11. Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis.
Balfour-Lynn IM; Lees B; Hall P; Phillips G; Khan M; Flather M; Elborn JS;
Am J Respir Crit Care Med; 2006 Jun; 173(12):1356-62. PubMed ID: 16556691
[TBL] [Abstract][Full Text] [Related]
12. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
[TBL] [Abstract][Full Text] [Related]
13. Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.
De Boeck K; Haarman E; Hull J; Lands LC; Moeller A; Munck A; Riethmüller J; Tiddens H; Volpi S; Leadbetter J; Charlton B; Malfroot A;
J Cyst Fibros; 2017 May; 16(3):380-387. PubMed ID: 28258928
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.
Ros M; Casciaro R; Lucca F; Troiani P; Salonini E; Favilli F; Quattrucci S; Sher D; Assael BM
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):133-7. PubMed ID: 23745525
[TBL] [Abstract][Full Text] [Related]
15. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
Aitken ML; Bellon G; De Boeck K; Flume PA; Fox HG; Geller DE; Haarman EG; Hebestreit HU; Lapey A; Schou IM; Zuckerman JB; Charlton B;
Am J Respir Crit Care Med; 2012 Mar; 185(6):645-52. PubMed ID: 22198974
[TBL] [Abstract][Full Text] [Related]
16. Improvement in clinical markers in CF patients using a reduced glutathione regimen: an uncontrolled, observational study.
Visca A; Bishop CT; Hilton SC; Hudson VM
J Cyst Fibros; 2008 Sep; 7(5):433-6. PubMed ID: 18499536
[TBL] [Abstract][Full Text] [Related]
17. [The effect of ipratropium bromide on lung function in patients with cystic fibrosis].
Wiebicke W; Poynter A; Montgomery M; Pagtakhan R
Pneumologie; 1990 Feb; 44 Suppl 1():277-8. PubMed ID: 2142293
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
[TBL] [Abstract][Full Text] [Related]
19. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein.
Grey V; Mohammed SR; Smountas AA; Bahlool R; Lands LC
J Cyst Fibros; 2003 Dec; 2(4):195-8. PubMed ID: 15463873
[TBL] [Abstract][Full Text] [Related]
20. Inhaled mannitol improves lung function in cystic fibrosis.
Jaques A; Daviskas E; Turton JA; McKay K; Cooper P; Stirling RG; Robertson CF; Bye PTP; LeSouëf PN; Shadbolt B; Anderson SD; Charlton B
Chest; 2008 Jun; 133(6):1388-1396. PubMed ID: 18339790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
